|
E-cigarettes: an evidence update
<br />
<br />90
<br />References
<br />1. National Institute for Health Care and Excellence. Tobacco: harm-reduction approaches to smoking. 2013;
<br />Available from: https://www.nice.org.uk/guidance/ph45/resources/guidance-tobacco-harmreduction-
<br />approaches-to-smoking-pdf.
<br />2. Jarvis, M.J. and J. Wardle, Social patterning of individual health behaviours: the case of cigarette smoking.
<br />Social determinants of health, 1999. 2: p. 224-37.
<br />3. Russel, M.A.H., The future of nicotine replacement. British Journal of Addiction, 1991. 86(5): p. 653-658.
<br />4. Gray, N.J., Nicotine yesterday, today, and tomorrow: A global review. Nicotine & Tobacco Research, 2013:
<br />p. ntt171.
<br />5. Chapman, S., E-cigarettes: the best and the worst case scenarios for public health—an essay by Simon
<br />Chapman. BMJ, 2014. 349: p. g5512.
<br />6. Dawkins, L. and O. Corcoran, Acute electronic cigarette use: nicotine delivery and subjective effects in
<br />regular users. Psychopharmacology (Berl), 2014. 231(2): p. 401-7.
<br />7. Vansickel, A.R. and T. Eissenberg, Electronic cigarettes: effective nicotine delivery after acute
<br />administration. Nicotine Tob Res, 2013. 15(1): p. 267-70.
<br />8. Etter, J.F., Levels of saliva cotinine in electronic cigarette users. Addiction, 2014. 109(5): p. 825-9.
<br />9. Etter, J.F. and C. Bullen, Saliva cotinine levels in users of electronic cigarettes. Eur Respir J, 2011. 38(5): p.
<br />1219-20.
<br />10. Nutt, D.J., et al., Estimating the harms of nicotine-containing products using the MCDA approach.
<br />European addiction research, 2014. 20(5): p. 218-225.
<br />11. Medicines & Healthcare Products Regulatory Agency. Licensing Procedure for Electronic Cigarettes and
<br />Other Nicotine Containing Products (NCPs) as Medicines, MHRA, Editor.
<br />12. EU Tobacco Directive. Revision of the Tobacco Products Directive. 2014 15 April 2015]; Available from:
<br />http://ec.europa.eu/health/tobacco/products/revision/index_en.htm.
<br />13. Office of National Statistics. Adult Smoking Habits in Great Britain, 2013. 2014 23 July 2015]; Available
<br />from: http://www.ons.gov.uk/ons/rel/ghs/opinions-and-lifestyle-survey/adult-smoking-habits-in-great-
<br />britain--2013/stb-opn-smoking-2013.html#tab-background-notes ).
<br />14. Action on Smoking and Health. Use of electronic cigarettes (vapourisers) among adults in Great Britain.
<br />2015 23 July 2015]; Available from: http://www.ash.org.uk/files/documents/ASH_891.pdf.
<br />15. Brown, J., R. West, and E. Beard, Smoking Toolkit Study. Trends in electronic cigarette use in England.
<br />http://www.smokinginengland.info/latest-statistics/, 2014. 23 April 2014.
<br />16. Hitchman, S.C., et al., Associations Between E-Cigarette Type, Frequency of Use, and Quitting Smoking:
<br />Findings From a Longitudinal Online Panel Survey in Great Britain. Nicotine Tob Res, 2015.
<br />17. HSCIC. Smoking, Drinking and Drug Use among Young people in England. 2014 18 May 2015]; Available
<br />from: http://www.hscic.gov.uk/article/3743/Smoking-Drinking-and-Drug-Use-among-Young-People-in-
<br />England.
<br />18. Moore, G., et al., Electronic-cigarette use among young people in Wales: evidence from two cross-
<br />sectional surveys. BMJ Open, 2015. 5(4): p. e007072.
<br />19. Moore, G.F., et al., E-cigarette use and intentions to smoke among 10-11-year-old never-smokers in
<br />Wales. Tob Control, 2014: p. tobaccocontrol-2014-052011.
<br />20. ISD Scotland. Scottish School's Adolescent Lifestyle and Substance Use Survey (SALSUS). 2014 18 May
<br />2015]; Available from: http://www.isdscotland.org/Health-Topics/Public-Health/SALSUS/.
<br />21. Hughes, K., et al., Associations between e-cigarette access and smoking and drinking behaviours in
<br />teenagers. BMC Public Health, 2015. 15(1): p. 244.
<br />22. Bell, K. and H. Keane, All gates lead to smoking: The ‘gateway theory’, e-cigarettes and the remaking of
<br />nicotine. Social Science & Medicine, 2014. 119: p. 45-52.
<br />23. Kandel, E.R. and D.B. Kandel, A molecular basis for nicotine as a gateway drug. New England Journal of
<br />Medicine, 2014. 371(10): p. 932-943.
|